X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6898) 6898
Newsletter (29) 29
Magazine Article (28) 28
Publication (17) 17
Dissertation (16) 16
Newspaper Article (16) 16
Book Chapter (11) 11
Book / eBook (4) 4
Transcript (4) 4
Book Review (3) 3
Web Resource (3) 3
Streaming Video (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5130) 5130
enoxaparin (4336) 4336
female (2904) 2904
male (2699) 2699
anticoagulants - therapeutic use (2128) 2128
middle aged (1972) 1972
enoxaparin - therapeutic use (1851) 1851
aged (1845) 1845
prevention (1678) 1678
venous thromboembolism (1635) 1635
molecular-weight heparin (1465) 1465
adult (1371) 1371
anticoagulants - administration & dosage (1263) 1263
anticoagulants (1220) 1220
enoxaparin - administration & dosage (1213) 1213
hematology (1213) 1213
treatment outcome (1159) 1159
anticoagulants - adverse effects (1143) 1143
unfractionated heparin (1123) 1123
thromboembolism (1120) 1120
surgery (1064) 1064
heparin (1060) 1060
peripheral vascular disease (1048) 1048
risk factors (970) 970
deep-vein thrombosis (952) 952
enoxaparin - adverse effects (935) 935
thrombosis (919) 919
thromboprophylaxis (889) 889
prophylaxis (814) 814
cardiac & cardiovascular systems (810) 810
venous thromboembolism - prevention & control (783) 783
medicine, general & internal (738) 738
pharmacology & pharmacy (723) 723
aged, 80 and over (691) 691
heparin, low-molecular-weight - therapeutic use (679) 679
venous thrombosis - prevention & control (671) 671
rivaroxaban (618) 618
drug therapy (615) 615
fibrinolytic agents - therapeutic use (612) 612
hemorrhage - chemically induced (601) 601
retrospective studies (581) 581
prospective studies (551) 551
heparin - therapeutic use (542) 542
warfarin (538) 538
postoperative complications - prevention & control (534) 534
thromboembolism - prevention & control (522) 522
risk (516) 516
abridged index medicus (488) 488
time factors (481) 481
therapy (478) 478
anticoagulation (470) 470
double-blind (460) 460
pulmonary-embolism (449) 449
medicine & public health (438) 438
safety (435) 435
factor xa inhibitors (429) 429
venous thrombosis (425) 425
anticoagulants - pharmacology (414) 414
low-molecular-weight heparin (414) 414
fondaparinux (412) 412
pulmonary embolism (408) 408
enoxaparin - pharmacology (403) 403
dose-response relationship, drug (402) 402
animals (390) 390
management (390) 390
pregnancy (390) 390
analysis (386) 386
low molecular weight heparin (380) 380
care and treatment (378) 378
pharmacokinetics (376) 376
risk assessment (373) 373
drug administration schedule (372) 372
venous thromboembolism - etiology (371) 371
administration, oral (362) 362
venous thrombosis - drug therapy (359) 359
aspirin (353) 353
health aspects (352) 352
mortality (351) 351
heparin, low-molecular-weight - administration & dosage (350) 350
randomized controlled trials as topic (347) 347
fibrinolytic agents - administration & dosage (338) 338
adolescent (335) 335
trial (332) 332
venous thrombosis - etiology (332) 332
orthopedics (331) 331
efficacy (328) 328
myocardial infarction - drug therapy (328) 328
acute coronary syndromes (327) 327
follow-up studies (310) 310
drug therapy, combination (308) 308
research (301) 301
pulmonary embolism - prevention & control (299) 299
metaanalysis (298) 298
double-blind method (297) 297
complications (294) 294
dosage and administration (294) 294
heparin - adverse effects (292) 292
incidence (292) 292
unstable angina (289) 289
arthroplasty (288) 288
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6416) 6416
German (156) 156
Spanish (135) 135
French (124) 124
Russian (73) 73
Portuguese (27) 27
Italian (19) 19
Polish (18) 18
Korean (12) 12
Chinese (11) 11
Japanese (11) 11
Turkish (9) 9
Czech (8) 8
Norwegian (7) 7
Danish (5) 5
Serbian (5) 5
Ukrainian (4) 4
Persian (3) 3
Arabic (2) 2
Finnish (2) 2
Slovenian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 15, pp. 1406 - 1415
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 9, pp. 799 - 808
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 6, pp. 513 - 523
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 26, pp. 2499 - 2510
In this clinical trial, rivaroxaban, an oral factor Xa inhibitor, was effective in the initial and continued treatment of symptomatic venous thromboembolism;... 
MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | THERAPY | DISEASE | PREVENTION | DEEP-VEIN THROMBOSIS | IDRAPARINUX | Thiophenes - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Injections, Subcutaneous | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Acute Disease | Double-Blind Method | Venous Thrombosis - drug therapy | Administration, Oral | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acenocoumarol - adverse effects | Intention to Treat Analysis | Pulmonary Embolism - drug therapy | Acenocoumarol - therapeutic use | Aged | Hemorrhage - chemically induced | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Health aspects | Risk factors | Anticoagulants | Bone surgery | Veins & arteries | Venous Thrombosis | Factor Xa | Hemorrhage | Life Sciences | Venous Thromboembolism | Thiophenes | Acenocoumarol | Vitamin K | Warfarin | Enoxaparin | Morpholines | Human health and pathology | Pulmonary Embolism | MEDICIN OCH HÄLSOVETENSKAP | Oral | MEDICAL AND HEALTH SCIENCES | Administration | chemically induced | drug therapy | Subcutaneous | antagonists & inhibitors | Injections | adverse effects | therapeutic use
Journal Article
7.